Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 692

1.

Bleeding signs due to acquired von Willebrand syndrome at diagnosis of chronic myeloid leukaemia in children.

Knöfler R, Lange BS, Paul F, Tiebel O, Suttorp M.

Br J Haematol. 2019 Oct 15. doi: 10.1111/bjh.16241. [Epub ahead of print]

PMID:
31617211
2.

Biocompatible conjugated fluorenylporphyrins for two-photon photodynamic therapy and fluorescence imaging.

Shi L, Nguyen C, Daurat M, Dhieb AC, Smirani W, Blanchard-Desce M, Gary-Bobo M, Mongin O, Paul-Roth C, Paul F.

Chem Commun (Camb). 2019 Oct 8;55(81):12231-12234. doi: 10.1039/c9cc05657b.

PMID:
31553001
3.

Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT study.

Balk LJ, Coric D, Knier B, Zimmermann HG, Behbehani R, Alroughani R, Martinez-Lapiscina EH, Brandt AU, Sánchez-Dalmau B, Vidal-Jordana A, Albrecht P, Koska V, Havla J, Pisa M, Nolan RC, Leocani L, Paul F, Aktas O, Montalban X, Balcer LJ, Villoslada P, Outteryck O, Korn T, Petzold A; IMSVISUAL consortium.

Mult Scler J Exp Transl Clin. 2019 Sep 5;5(3):2055217319871582. doi: 10.1177/2055217319871582. eCollection 2019 Jul-Sep.

4.

Brain iron and metabolic abnormalities in C19orf12 mutation carriers: A 7.0 tesla MRI study in mitochondrial membrane protein-associated neurodegeneration.

Dusek P, Mekle R, Skowronska M, Acosta-Cabronero J, Huelnhagen T, Robinson SD, Schubert F, Deschauer M, Els A, Ittermann B, Schottmann G, Madai VI, Paul F, Klopstock T, Kmiec T, Niendorf T, Wuerfel J, Schneider SA.

Mov Disord. 2019 Sep 13. doi: 10.1002/mds.27827. [Epub ahead of print]

PMID:
31518459
5.

Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis.

Pfuhl C, Grittner U, Gieß RM, Scheel M, Behrens JR, Rasche L, Pache FC, Wenzel R, Brandt AU, Bellmann-Strobl J, Paul F, Ruprecht K, Oechtering J.

Neurology. 2019 Oct 8;93(15):e1439-e1451. doi: 10.1212/WNL.0000000000008237. Epub 2019 Sep 9.

PMID:
31501228
6.

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.

Cree BAC, Bennett JL, Kim HJ, Weinshenker BG, Pittock SJ, Wingerchuk DM, Fujihara K, Paul F, Cutter GR, Marignier R, Green AJ, Aktas O, Hartung HP, Lublin FD, Drappa J, Barron G, Madani S, Ratchford JN, She D, Cimbora D, Katz E; N-MOmentum study investigators.

Lancet. 2019 Oct 12;394(10206):1352-1363. doi: 10.1016/S0140-6736(19)31817-3. Epub 2019 Sep 5.

PMID:
31495497
7.

Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.

Sinnecker T, Clarke MA, Meier D, Enzinger C, Calabrese M, De Stefano N, Pitiot A, Giorgio A, Schoonheim MM, Paul F, Pawlak MA, Schmidt R, Kappos L, Montalban X, Rovira À, Evangelou N, Wuerfel J; MAGNIMS Study Group.

JAMA Neurol. 2019 Aug 19. doi: 10.1001/jamaneurol.2019.2478. [Epub ahead of print]

PMID:
31424490
8.

Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?

Stiebel-Kalish H, Hellmann MA, Mimouni M, Paul F, Bialer O, Bach M, Lotan I.

Neurol Neuroimmunol Neuroinflamm. 2019 May 21;6(4):e572. doi: 10.1212/NXI.0000000000000572. eCollection 2019 Jul.

9.

Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study.

Oertel FC, Outteryck O, Knier B, Zimmermann H, Borisow N, Bellmann-Strobl J, Blaschek A, Jarius S, Reindl M, Ruprecht K, Meinl E, Hohlfeld R, Paul F, Brandt AU, Kümpfel T, Havla J.

J Neuroinflammation. 2019 Jul 25;16(1):154. doi: 10.1186/s12974-019-1521-5.

10.

Fluorenylporphyrins functionalized by electrochromic ruthenium units as redox-triggered fluorescence switches.

Zhang X, Abid S, Shi L, Williams JAG, Fox MA, Miomandre F, Tourbillon C, Audibert JF, Mongin O, Paul F, Paul-Roth CO.

Dalton Trans. 2019 Aug 21;48(31):11897-11911. doi: 10.1039/c9dt02087j. Epub 2019 Jul 16.

PMID:
31310264
11.

[Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany].

Bittner S, Engel S, Lange C, Weber MS, Haghikia A, Luessi F, Korn T, Klotz L, Bayas A, Paul F, Heesen C, Stangel M, Wildemann B, Bergh FT, Tackenberg B, Trebst C, Warnke C, Linker R, Kerschensteiner M, Zettl U, Tumani H, Brück W, Meuth SG, Kümpfel T, Hemmer B, Wiendl H, Gold R, Zipp F.

Nervenarzt. 2019 Jul 11. doi: 10.1007/s00115-019-0760-0. [Epub ahead of print] Review. German.

PMID:
31297574
12.

Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial.

Levin J, Maaß S, Schuberth M, Giese A, Oertel WH, Poewe W, Trenkwalder C, Wenning GK, Mansmann U, Südmeyer M, Eggert K, Mollenhauer B, Lipp A, Löhle M, Classen J, Münchau A, Kassubek J, Gandor F, Berg D, Egert-Schwender S, Eberhardt C, Paul F, Bötzel K, Ertl-Wagner B, Huppertz HJ, Ricard I, Höglinger GU; PROMESA Study Group.

Lancet Neurol. 2019 Aug;18(8):724-735. doi: 10.1016/S1474-4422(19)30141-3. Epub 2019 Jul 2.

PMID:
31278067
13.

Frequency of autoimmune disorders and autoantibodies in European patients with neuromyelitis optica spectrum disorders.

Gkaniatsou T, Papadopoulou A, Paul F, Brandt AU, Oertel FC.

Acta Neurol Belg. 2019 Jul 1. doi: 10.1007/s13760-019-01176-6. [Epub ahead of print] No abstract available.

PMID:
31264181
14.

Cognitive Impairment in Neuromyelitis Optica Spectrum Disorders: A Review of Clinical and Neuroradiological Features.

Oertel FC, Schließeit J, Brandt AU, Paul F.

Front Neurol. 2019 Jun 12;10:608. doi: 10.3389/fneur.2019.00608. eCollection 2019. Review.

15.

Canine Brucellosis: Insights Into the Epidemiologic Situation in Europe.

Buhmann G, Paul F, Herbst W, Melzer F, Wolf G, Hartmann K, Fischer A.

Front Vet Sci. 2019 May 31;6:151. doi: 10.3389/fvets.2019.00151. eCollection 2019.

16.

Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines.

Filippi M, Preziosa P, Banwell BL, Barkhof F, Ciccarelli O, De Stefano N, Geurts JJG, Paul F, Reich DS, Toosy AT, Traboulsee A, Wattjes MP, Yousry TA, Gass A, Lubetzki C, Weinshenker BG, Rocca MA.

Brain. 2019 Jul 1;142(7):1858-1875. doi: 10.1093/brain/awz144.

17.

Neural mechanisms of perceptual decision-making and their link to neuropsychiatric symptoms in multiple sclerosis.

Weygandt M, Behrens J, Brasanac J, Söder E, Meyer-Arndt L, Wakonig K, Ritter K, Brandt AU, Bellmann-Strobl J, Gold SM, Haynes JD, Paul F.

Mult Scler Relat Disord. 2019 Aug;33:139-145. doi: 10.1016/j.msard.2019.05.025. Epub 2019 May 30.

PMID:
31195338
18.

Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy.

Klehmet J, Beutner S, Hoffmann S, Dornauer M, Paul F, Reilmann R, Brandt AU, Meisel A.

BMC Neurol. 2019 Jun 8;19(1):118. doi: 10.1186/s12883-019-1339-x.

19.

Olfactory and Gustatory Dysfunction in Patients With Autoimmune Encephalitis.

Geran R, Uecker FC, Prüss H, Haeusler KG, Paul F, Ruprecht K, Harms L, Schmidt FA.

Front Neurol. 2019 May 14;10:480. doi: 10.3389/fneur.2019.00480. eCollection 2019.

20.

Vision and Vision-Related Measures in Progressive Multiple Sclerosis.

Backner Y, Petrou P, Glick-Shames H, Raz N, Zimmermann H, Jost R, Scheel M, Paul F, Karussis D, Levin N.

Front Neurol. 2019 May 3;10:455. doi: 10.3389/fneur.2019.00455. eCollection 2019.

21.

Attack-related damage of thalamic nuclei in neuromyelitis optica spectrum disorders.

Papadopoulou A, Oertel FC, Gaetano L, Kuchling J, Zimmermann H, Chien C, Siebert N, Asseyer S, Bellmann-Strobl J, Ruprecht K, Chakravarty MM, Scheel M, Magon S, Wuerfel J, Paul F, Brandt AU.

J Neurol Neurosurg Psychiatry. 2019 Oct;90(10):1156-1164. doi: 10.1136/jnnp-2018-320249. Epub 2019 May 24.

PMID:
31127016
22.

Variational selection of features for molecular kinetics.

Scherer MK, Husic BE, Hoffmann M, Paul F, Wu H, Noé F.

J Chem Phys. 2019 May 21;150(19):194108. doi: 10.1063/1.5083040.

PMID:
31117766
23.

MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing.

Keren-Shaul H, Kenigsberg E, Jaitin DA, David E, Paul F, Tanay A, Amit I.

Nat Protoc. 2019 Jun;14(6):1841-1862. doi: 10.1038/s41596-019-0164-4. Epub 2019 May 17.

PMID:
31101904
24.

Active contour method for ILM segmentation in ONH volume scans in retinal OCT.

Gawlik K, Hausser F, Paul F, Brandt AU, Kadas EM.

Biomed Opt Express. 2018 Nov 28;9(12):6497-6518. doi: 10.1364/BOE.9.006497. eCollection 2018 Dec 1.

25.

Identification of kinetic order parameters for non-equilibrium dynamics.

Paul F, Wu H, Vossel M, de Groot BL, Noé F.

J Chem Phys. 2019 Apr 28;150(16):164120. doi: 10.1063/1.5083627.

PMID:
31042914
26.

Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis.

Gasperi C, Salmen A, Antony G, Bayas A, Heesen C, Kümpfel T, Linker RA, Paul F, Stangel M, Tackenberg B, Bergh FT, Warnke C, Weber F, Wiendl H, Wildemann B, Zettl UK, Ziemann U, Zipp F, Tumani H, Gold R, Hemmer B; German Competence Network of Multiple Sclerosis.

JAMA Neurol. 2019 Jul 1;76(7):841-849. doi: 10.1001/jamaneurol.2019.0905.

PMID:
31034002
27.

Increased Retention of Gadolinium in the Inflamed Brain After Repeated Administration of Gadopentetate Dimeglumine: A Proof-of-Concept Study in Mice Combining ICP-MS and Micro- and Nano-SR-XRF.

Wang S, Hesse B, Roman M, Stier D, Castillo-Michel H, Cotte M, Suuronen JP, Lagrange A, Radbruch H, Paul F, Taupitz M, Schellenberger E, Sack I, Infante-Duarte C.

Invest Radiol. 2019 Oct;54(10):617-626. doi: 10.1097/RLI.0000000000000571.

PMID:
31033673
28.

Standardization of T1w/T2w Ratio Improves Detection of Tissue Damage in Multiple Sclerosis.

Cooper G, Finke C, Chien C, Brandt AU, Asseyer S, Ruprecht K, Bellmann-Strobl J, Paul F, Scheel M.

Front Neurol. 2019 Apr 9;10:334. doi: 10.3389/fneur.2019.00334. eCollection 2019.

29.

The mechanism of RNA base fraying: Molecular dynamics simulations analyzed with core-set Markov state models.

Pinamonti G, Paul F, Noé F, Rodriguez A, Bussi G.

J Chem Phys. 2019 Apr 21;150(15):154123. doi: 10.1063/1.5083227.

PMID:
31005065
30.

MAPK pathway and B cells overactivation in multiple sclerosis revealed by phosphoproteomics and genomic analysis.

Kotelnikova E, Kiani NA, Messinis D, Pertsovskaya I, Pliaka V, Bernardo-Faura M, Rinas M, Vila G, Zubizarreta I, Pulido-Valdeolivas I, Sakellaropoulos T, Faigle W, Silberberg G, Masso M, Stridh P, Behrens J, Olsson T, Martin R, Paul F, Alexopoulos LG, Saez-Rodriguez J, Tegner J, Villoslada P.

Proc Natl Acad Sci U S A. 2019 May 7;116(19):9671-9676. doi: 10.1073/pnas.1818347116. Epub 2019 Apr 19.

PMID:
31004050
31.

Association of Occupational Pesticide Exposure With Immunochemotherapy Response and Survival Among Patients With Diffuse Large B-Cell Lymphoma.

Lamure S, Carles C, Aquereburu Q, Quittet P, Tchernonog E, Paul F, Jourdan E, Waultier A, Defez C, Belhadj I, Sanhes L, Burcheri S, Donadio D, Exbrayat C, Saad A, Labourey JL, Baldi I, Cartron G, Fabbro-Peray P.

JAMA Netw Open. 2019 Apr 5;2(4):e192093. doi: 10.1001/jamanetworkopen.2019.2093.

32.

Global glacier mass changes and their contributions to sea-level rise from 1961 to 2016.

Zemp M, Huss M, Thibert E, Eckert N, McNabb R, Huber J, Barandun M, Machguth H, Nussbaumer SU, Gärtner-Roer I, Thomson L, Paul F, Maussion F, Kutuzov S, Cogley JG.

Nature. 2019 Apr;568(7752):382-386. doi: 10.1038/s41586-019-1071-0. Epub 2019 Apr 8.

PMID:
30962533
33.

Nightmares do result in psychophysiological arousal: A multimeasure ambulatory assessment study.

Paul F, Alpers GW, Reinhard I, Schredl M.

Psychophysiology. 2019 Jul;56(7):e13366. doi: 10.1111/psyp.13366. Epub 2019 Mar 30.

PMID:
30927477
34.

Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica.

Pasquier B, Borisow N, Rasche L, Bellmann-Strobl J, Ruprecht K, Niendorf T, Derfuss TJ, Wuerfel J, Paul F, Sinnecker T.

Neurol Neuroimmunol Neuroinflamm. 2019 Mar 7;6(3):e541. doi: 10.1212/NXI.0000000000000541. eCollection 2019 May.

35.

Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study.

Olesen MN, Soelberg K, Debrabant B, Nilsson AC, Lillevang ST, Grauslund J, Brandslund I, Madsen JS, Paul F, Smith TJ, Jarius S, Asgari N.

J Neuroinflammation. 2019 Mar 11;16(1):59. doi: 10.1186/s12974-019-1440-5.

36.

Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: An international study.

Nolan-Kenney RC, Liu M, Akhand O, Calabresi PA, Paul F, Petzold A, Balk L, Brandt AU, Martínez-Lapiscina EH, Saidha S, Villoslada P, Al-Hassan AA, Behbehani R, Frohman EM, Frohman T, Havla J, Hemmer B, Jiang H, Knier B, Korn T, Leocani L, Papadopoulou A, Pisa M, Zimmermann H, Galetta SL, Balcer LJ; International Multiple Sclerosis Visual System Consortium.

Ann Neurol. 2019 May;85(5):618-629. doi: 10.1002/ana.25462. Epub 2019 Apr 10.

PMID:
30851125
37.

Leptomeningeal and Intraparenchymal Blood Barrier Disruption in a MOG-IgG-Positive Patient.

Mohseni SH, Skejoe HPB, Wuerfel J, Paul F, Reindl M, Jarius S, Asgari N.

Case Rep Neurol Med. 2018 Dec 9;2018:1365175. doi: 10.1155/2018/1365175. eCollection 2018.

38.
39.

The use of magnetic resonance imaging in the diagnosis of paediatric transverse myelitis.

Paul F.

Dev Med Child Neurol. 2019 Sep;61(9):1001. doi: 10.1111/dmcn.14171. Epub 2019 Feb 5. No abstract available.

PMID:
30720201
40.

Less Is More - Estimation of the Number of Strides Required to Assess Gait Variability in Spatially Confined Settings.

Kroneberg D, Elshehabi M, Meyer AC, Otte K, Doss S, Paul F, Nussbaum S, Berg D, Kühn AA, Maetzler W, Schmitz-Hübsch T.

Front Aging Neurosci. 2019 Jan 21;10:435. doi: 10.3389/fnagi.2018.00435. eCollection 2018.

41.

Differential Impact According to Mission's Operational Intensity on Psychoactive Substance Use: A Retrospective Cohort of French Male Army Service Members.

Marchi J, Mayet A, Chamonaz C, de Laval F, Paul F, Marimoutou C.

Subst Use Misuse. 2019;54(5):841-851. doi: 10.1080/10826084.2018.1547908. Epub 2019 Jan 16.

PMID:
30648459
42.

Chi3l3 induces oligodendrogenesis in an experimental model of autoimmune neuroinflammation.

Starossom SC, Campo Garcia J, Woelfle T, Romero-Suarez S, Olah M, Watanabe F, Cao L, Yeste A, Tukker JJ, Quintana FJ, Imitola J, Witzel F, Schmitz D, Morkel M, Paul F, Infante-Duarte C, Khoury SJ.

Nat Commun. 2019 Jan 15;10(1):217. doi: 10.1038/s41467-018-08140-7.

43.

Competency-based Professional Advancement Model for Advanced Practice RNs.

Paul F, Abecassis L, Freiberger D, Hamilton S, Kelly P, Klements E, LaGrasta C, Lemire L, OʼDonnell E, Patisteas E, Phinney C, Conwell K, Saia T, Whelan K, Wood LJ, OʼBrien P.

J Nurs Adm. 2019 Feb;49(2):66-72. doi: 10.1097/NNA.0000000000000719.

PMID:
30640314
44.

N2 year in review and message from the editor to our reviewers.

Dalmau J, Kolson DL, Paul F, Zamvil SS.

Neurol Neuroimmunol Neuroinflamm. 2018 Dec 19;6(1):e525. doi: 10.1212/NXI.0000000000000525. eCollection 2019 Jan. No abstract available.

45.

CSF-Progranulin and Neurofilament Light Chain Levels in Patients With Radiologically Isolated Syndrome-Sign of Inflammation.

Pawlitzki M, Sweeney-Reed CM, Bittner D, Lux A, Vielhaber S, Schreiber S, Paul F, Neumann J.

Front Neurol. 2018 Dec 18;9:1075. doi: 10.3389/fneur.2018.01075. eCollection 2018.

46.

Novel uses of retinal imaging with optical coherence tomography in multiple sclerosis.

Oertel FC, Zimmermann HG, Brandt AU, Paul F.

Expert Rev Neurother. 2019 Jan;19(1):31-43. doi: 10.1080/14737175.2019.1559051. Epub 2018 Dec 27.

PMID:
30587061
47.

Infusion-related reactions to rituximab: frequency, mechanisms and predictors.

Paul F, Cartron G.

Expert Rev Clin Immunol. 2019 Apr;15(4):383-389. doi: 10.1080/1744666X.2019.1562905. Epub 2019 Jan 11.

PMID:
30580638
48.

Gadolinium in human brain sections and colocalization with other elements.

El-Khatib AH, Radbruch H, Trog S, Neumann B, Paul F, Koch A, Linscheid MW, Jakubowski N, Schellenberger E.

Neurol Neuroimmunol Neuroinflamm. 2018 Oct 19;6(1):e515. doi: 10.1212/NXI.0000000000000515. eCollection 2019 Jan. No abstract available.

49.

Metabolic, Mental and Immunological Effects of Normoxic and Hypoxic Training in Multiple Sclerosis Patients: A Pilot Study.

Mähler A, Balogh A, Csizmadia I, Klug L, Kleinewietfeld M, Steiniger J, Šušnjar U, Müller DN, Boschmann M, Paul F.

Front Immunol. 2018 Nov 29;9:2819. doi: 10.3389/fimmu.2018.02819. eCollection 2018.

50.

Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions.

Mealy MA, Mossburg SE, Kim SH, Messina S, Borisow N, Lopez-Gonzalez R, Ospina JP, Scheel M, Yeshokumar AK, Awad A, Leite MI, Arango JJ, Paul F, Palace J, Kim HJ, Levy M.

Mult Scler Relat Disord. 2019 Feb;28:64-68. doi: 10.1016/j.msard.2018.12.011. Epub 2018 Dec 9.

PMID:
30554040

Supplemental Content

Support Center